Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3,4,5-Trimethoxybenzoyl chloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

4521-61-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • sulfuric acid [(8R,9S,13S,14S,16R,17R)-3,16-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester

    Cas No: 4521-61-3

  • No Data

  • 10 Milligram

  • Amadis Chemical Co., Ltd.
  • Contact Supplier
  • 4521-61-3 Structure
  • Basic information

    1. Product Name: 3,4,5-Trimethoxybenzoyl chloride
    2. Synonyms: 3,4,5-trimethoxy-benzoylchlorid;Benzoyl chloride, 3,4,5-trimethoxy-;Trimethylgalloyl chloride;Tri-O-methylgalloyl chloride;AKOS BBS-00003922;3,4,5-TRIMETHOXYBENZOYL CHLORIDE;3,4,5-Trimethoxybenzoic acid chloride
    3. CAS NO:4521-61-3
    4. Molecular Formula: C10H11ClO4
    5. Molecular Weight: 230.64
    6. EINECS: 224-851-4
    7. Product Categories: Acid Halides;Carbonyl Compounds;Organic Building Blocks;Acid Halides;Building Blocks;Carbonyl Compounds;Chemical Synthesis;Organic Building Blocks
    8. Mol File: 4521-61-3.mol
    9. Article Data: 109
  • Chemical Properties

    1. Melting Point: 81-84 °C(lit.)
    2. Boiling Point: 185 °C18 mm Hg(lit.)
    3. Flash Point: 185°C/18mm
    4. Appearance: White crystal
    5. Density: 1,214 g/cm3
    6. Vapor Pressure: 0.000458mmHg at 25°C
    7. Refractive Index: 1.4571 (estimate)
    8. Storage Temp.: Store at 0-5°C
    9. Solubility: soluble in Toluene
    10. Sensitive: Moisture Sensitive
    11. BRN: 403117
    12. CAS DataBase Reference: 3,4,5-Trimethoxybenzoyl chloride(CAS DataBase Reference)
    13. NIST Chemistry Reference: 3,4,5-Trimethoxybenzoyl chloride(4521-61-3)
    14. EPA Substance Registry System: 3,4,5-Trimethoxybenzoyl chloride(4521-61-3)
  • Safety Data

    1. Hazard Codes: C
    2. Statements: 14-34-37
    3. Safety Statements: 26-36/37/39-45
    4. RIDADR: UN 3261 8/PG 2
    5. WGK Germany: 1
    6. RTECS:
    7. F: 9-21
    8. HazardClass: 8
    9. PackingGroup: II
    10. Hazardous Substances Data: 4521-61-3(Hazardous Substances Data)

4521-61-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4521-61-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,2 and 1 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4521-61:
(6*4)+(5*5)+(4*2)+(3*1)+(2*6)+(1*1)=73
73 % 10 = 3
So 4521-61-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H11ClO4/c1-13-7-4-6(10(11)12)5-8(14-2)9(7)15-3/h4-5H,1-3H3

4521-61-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L04779)  3,4,5-Trimethoxybenzoyl chloride, 98%   

  • 4521-61-3

  • 25g

  • 268.0CNY

  • Detail
  • Alfa Aesar

  • (L04779)  3,4,5-Trimethoxybenzoyl chloride, 98%   

  • 4521-61-3

  • 100g

  • 754.0CNY

  • Detail
  • Aldrich

  • (T69809)  3,4,5-Trimethoxybenzoylchloride  98%

  • 4521-61-3

  • T69809-25G

  • 1,030.77CNY

  • Detail

4521-61-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4,5-Trimethoxybenzoyl chloride

1.2 Other means of identification

Product number -
Other names Benzoyl chloride, 3,4,5-trimethoxy-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4521-61-3 SDS

4521-61-3Synthetic route

Eudesmic acid
118-41-2

Eudesmic acid

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

Conditions
ConditionsYield
With thionyl chloride In dichloromethane Heating;100%
With thionyl chloride In chloroform for 4h; Reflux;100%
With thionyl chloride In CH2C3 for 3h; Reflux;100%
phosphorus pentachloride
10026-13-8, 874483-75-7

phosphorus pentachloride

Eudesmic acid
118-41-2

Eudesmic acid

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

carbon disulfide
75-15-0

carbon disulfide

phosphorus pentachloride
10026-13-8, 874483-75-7

phosphorus pentachloride

Eudesmic acid
118-41-2

Eudesmic acid

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

phosphorus pentachloride
10026-13-8, 874483-75-7

phosphorus pentachloride

Eudesmic acid
118-41-2

Eudesmic acid

benzene
71-43-2

benzene

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

methyl syringate
884-35-5

methyl syringate

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Bu4NHSO4, K2CO3 / toluene / 6 h / Heating
2: 2M aq. NaOH / various solvent(s) / 0.25 h
3: thionyl chloride / 2 h / Heating
View Scheme
3,4,5-trimethoxybenzoic acid methyl ester
1916-07-0

3,4,5-trimethoxybenzoic acid methyl ester

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2M aq. NaOH / various solvent(s) / 0.25 h
2: thionyl chloride / 2 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: potassium hydroxide / ethanol; water / 3 h / Reflux
2: thionyl chloride / 21 h / 80 °C
View Scheme
Multi-step reaction with 2 steps
1: potassium hydroxide / ethanol / 48 h / Reflux
2: thionyl chloride / 4 h / Inert atmosphere; Reflux
View Scheme
Multi-step reaction with 2 steps
1: potassium hydroxide / ethanol / 48 h / Reflux
2: thionyl chloride / 4 h / Inert atmosphere; Reflux
View Scheme
ethyl 3,4,5-trimethoxybenzoate
6178-44-5

ethyl 3,4,5-trimethoxybenzoate

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide; ethanol / Inert atmosphere; Schlenk technique
2: thionyl chloride / Inert atmosphere; Schlenk technique
View Scheme
3,4,5-trimethoxy-benzaldehyde
86-81-7

3,4,5-trimethoxy-benzaldehyde

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: urea hydrogen peroxide adduct / methanol / 1.5 h / Reflux
2: thionyl chloride / N,N-dimethyl-formamide; dichloromethane / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: potassium permanganate / water; acetone / 25 °C
2: oxalyl dichloride; N,N-dimethyl-formamide / dichloromethane / 0 - 25 °C / Inert atmosphere
View Scheme
penfluridol
26864-56-2

penfluridol

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

1-<4,4-Bis(4-fluorophenyl)butyl>-4-(4-chloro-3-trifluoromethylphenyl)-4-piperidyl 3,4,5-Trimethoxybenzoate
80458-78-2

1-<4,4-Bis(4-fluorophenyl)butyl>-4-(4-chloro-3-trifluoromethylphenyl)-4-piperidyl 3,4,5-Trimethoxybenzoate

Conditions
ConditionsYield
In chloroform Ambient temperature; overnight;100%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

6-Hydroxy-1,3-diphenyl-2,4-dithioxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester

6-Hydroxy-1,3-diphenyl-2,4-dithioxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester

4-Oxo-1,3-diphenyl-2-thioxo-6-(3,4,5-trimethoxy-benzoylsulfanyl)-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester

4-Oxo-1,3-diphenyl-2-thioxo-6-(3,4,5-trimethoxy-benzoylsulfanyl)-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With pyridine; sodium hydroxide In 1,4-dioxane 1.) r.t., 10 min, 2.) 65 deg C - 70 deg C, 3 h;100%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

2-(N-formyl)-methylamino-2-phenylbutanol
294882-34-1

2-(N-formyl)-methylamino-2-phenylbutanol

3,4,5-trimethoxy-benzoic acid 2-(formyl-methyl-amino)-2-phenyl-butyl ester

3,4,5-trimethoxy-benzoic acid 2-(formyl-methyl-amino)-2-phenyl-butyl ester

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran; hexane Acylation;100%
isocyanoacetic acid methyl ester
39687-95-1

isocyanoacetic acid methyl ester

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

4-methoxycarbonyl-5-(3,4,5-trimethoxyphenyl)-oxazole
38061-20-0

4-methoxycarbonyl-5-(3,4,5-trimethoxyphenyl)-oxazole

Conditions
ConditionsYield
With P(MeNCH2CH2)3N In tetrahydrofuran 1.) 5 deg C, 15 min, 2.) r.t., 30 min;99%
With triethylamine
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

3-iodo-5-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene
334708-34-8

3-iodo-5-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene

[5-methoxy-2-(4-methoxy-phenyl)-benzo[b]thiophen-3-yl]-(3,4,5-trimethoxy-phenyl)-methanone

[5-methoxy-2-(4-methoxy-phenyl)-benzo[b]thiophen-3-yl]-(3,4,5-trimethoxy-phenyl)-methanone

Conditions
ConditionsYield
With n-butyllithium In tetrahydrofuran99%
DL-alanine ethyl ester hydrochloride
617-27-6

DL-alanine ethyl ester hydrochloride

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

rac-ethyl 2-(3,4,5-trimethoxybenzamido)propanoate
1423044-62-5

rac-ethyl 2-(3,4,5-trimethoxybenzamido)propanoate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;99%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

ethyl (3-amino-5-nitrobenzothiophen)-2-carboxylate
27697-60-5

ethyl (3-amino-5-nitrobenzothiophen)-2-carboxylate

ethyl 3-(3,4,5-trimethoxybenzoylamino)-5-nitrobenzo[b]thiophene-2-carboxylate

ethyl 3-(3,4,5-trimethoxybenzoylamino)-5-nitrobenzo[b]thiophene-2-carboxylate

Conditions
ConditionsYield
With pyridine at 20℃; for 12h;99%
azetion-3-ol hydrochloride
18621-18-6

azetion-3-ol hydrochloride

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

(3-hydroxyazetidin-1-yl)(3,4,5-trimethoxyphenyl)methanone

(3-hydroxyazetidin-1-yl)(3,4,5-trimethoxyphenyl)methanone

Conditions
ConditionsYield
Stage #1: azetion-3-ol hydrochloride; 3,4,5-Trimethoxybenzoyl chloride With potassium carbonate In water; ethyl acetate at 20℃; for 16h;
Stage #2: With sodium hydroxide In tetrahydrofuran; methanol; water for 20h;
99%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

benzylamine
100-46-9

benzylamine

N-benzyl-3,4,5-trimethoxybenzamide
3940-84-9

N-benzyl-3,4,5-trimethoxybenzamide

Conditions
ConditionsYield
With triethylamine; calcium chloride at 0 - 20℃; for 2h;98%
With diethyl ether
With TEA In tetrahydrofuran at 20℃;
In dichloromethane at 0℃;
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

(R)-2-Benzo[1,3]dioxol-5-ylmethyl-piperidine
135241-35-9

(R)-2-Benzo[1,3]dioxol-5-ylmethyl-piperidine

((R)-2-Benzo[1,3]dioxol-5-ylmethyl-piperidin-1-yl)-(3,4,5-trimethoxy-phenyl)-methanone
135241-36-0

((R)-2-Benzo[1,3]dioxol-5-ylmethyl-piperidin-1-yl)-(3,4,5-trimethoxy-phenyl)-methanone

Conditions
ConditionsYield
With sodium hydroxide In dichloromethane; water98%
1,6-Hexanediamine
124-09-4

1,6-Hexanediamine

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

C26H36N2O8

C26H36N2O8

Conditions
ConditionsYield
With potassium carbonate In water; ethyl acetate98%
With aq. KaCO3 In ethyl acetate
1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid ; hydrochloride
41994-51-8

1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid ; hydrochloride

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

2-(3,4,5-trimethoxybenzoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
1262971-70-9

2-(3,4,5-trimethoxybenzoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

Conditions
ConditionsYield
Stage #1: 1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid ; hydrochloride With sodium hydroxide In acetone at 20℃;
Stage #2: 3,4,5-Trimethoxybenzoyl chloride With sodium hydroxide In acetone at 20℃; pH=> 10;
Stage #3: With hydrogenchloride In water pH=5 - 6;
98%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

5,7,3',4'-tetra-O-benzyl-(+)-catechin
20728-73-8

5,7,3',4'-tetra-O-benzyl-(+)-catechin

5,7,3',4'-tetra-O-benzyl-3-O-(3'',4'',5''-trimethoxybenzoyl)-(-)catechin
1282609-48-6

5,7,3',4'-tetra-O-benzyl-3-O-(3'',4'',5''-trimethoxybenzoyl)-(-)catechin

Conditions
ConditionsYield
With dmap In dichloromethane at 20℃; for 18h; Inert atmosphere;98%
With dmap In dichloromethane at 20℃; for 18h;
5,6-dihydro-4H-benzo[f][1,2,3]triazolo[1,5-a][1,4]diazepine

5,6-dihydro-4H-benzo[f][1,2,3]triazolo[1,5-a][1,4]diazepine

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

C20H20N4O4
1358786-77-2

C20H20N4O4

Conditions
ConditionsYield
With triethylamine In dichloromethane98%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

4,4'-dimethoxy-5,6,5',6'-dimethylenedioxy-2,2'-dibenzyl alcohol
90749-17-0, 79279-08-6

4,4'-dimethoxy-5,6,5',6'-dimethylenedioxy-2,2'-dibenzyl alcohol

(4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-diyl)-bis(methylene) bis(3,4,5-trimethoxybenzoate)
1377829-18-9

(4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-diyl)-bis(methylene) bis(3,4,5-trimethoxybenzoate)

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;98%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

methyl L-fucopyranoside
14687-15-1

methyl L-fucopyranoside

methyl 3-O-3,4,5-trimethylgalloyl-α-L-fucopyranoside

methyl 3-O-3,4,5-trimethylgalloyl-α-L-fucopyranoside

Conditions
ConditionsYield
With 4-methoxy-2-(N-methylimidazolyl)phenylboronic acid; N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 20℃; for 7h; Inert atmosphere;98%
methyl 6-aminocaproate hydrochloride
1926-80-3

methyl 6-aminocaproate hydrochloride

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

methyl 6-(3,4,5-trimethoxybenzamido)hexanoate
50348-25-9

methyl 6-(3,4,5-trimethoxybenzamido)hexanoate

Conditions
ConditionsYield
With triethylamine In chloroform-d1 at 0℃; Acylation;97%
4-(Ethyl)cyclohexylamine
42195-97-1

4-(Ethyl)cyclohexylamine

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

N-(4-ethyl-cyclohexyl)-3,4,5-trimethoxy-benzamide

N-(4-ethyl-cyclohexyl)-3,4,5-trimethoxy-benzamide

Conditions
ConditionsYield
With triethylamine In benzene at 20℃; Acylation;97%
Homophthalic acid
89-51-0

Homophthalic acid

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

3-(3,4,5-trimethoxyphenyl)-1H-2-benzopyran-1-one
176972-44-4

3-(3,4,5-trimethoxyphenyl)-1H-2-benzopyran-1-one

Conditions
ConditionsYield
at 150℃; Microwave irradiation;97%
at 200℃;87%
2-nitro-4-fluoroaniline
364-78-3

2-nitro-4-fluoroaniline

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

[N-(4-Fluoro-2-nitrophenyl)]3,4,5-trimethoxybenzylamide
332015-13-1

[N-(4-Fluoro-2-nitrophenyl)]3,4,5-trimethoxybenzylamide

Conditions
ConditionsYield
With pyridine In dichloromethane97%
With pyridine In dichloromethane66%
4-Aminobutanol
13325-10-5

4-Aminobutanol

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

N-(4-hydroxybutyl)-3,4,5-trimethoxybenzamide

N-(4-hydroxybutyl)-3,4,5-trimethoxybenzamide

Conditions
ConditionsYield
Stage #1: 3,4,5-Trimethoxybenzoyl chloride With potassium carbonate In dichloromethane for 0.5h; Cooling with ice;
Stage #2: 4-Aminobutanol In dichloromethane at 20℃; for 24h;
97%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

(4S,5S)-4-Benzo[1,3]dioxol-5-yl-2,2-dimethyl-[1,3]dioxan-5-ylamine
127951-19-3

(4S,5S)-4-Benzo[1,3]dioxol-5-yl-2,2-dimethyl-[1,3]dioxan-5-ylamine

N-((4R,5R)-4-Benzo[1,3]dioxol-5-yl-2,2-dimethyl-[1,3]dioxan-5-yl)-3,4,5-trimethoxy-benzamide
127951-20-6, 127951-27-3

N-((4R,5R)-4-Benzo[1,3]dioxol-5-yl-2,2-dimethyl-[1,3]dioxan-5-yl)-3,4,5-trimethoxy-benzamide

Conditions
ConditionsYield
With pyridine; dmap for 1.5h; 0 deg C to room temp.;96%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

5,7,7-trimethyl-6-oxa-3-azabicyclo<3.2.2>nonane

5,7,7-trimethyl-6-oxa-3-azabicyclo<3.2.2>nonane

(3,4,5-Trimethoxy-phenyl)-((1R,5S)-5,7,7-trimethyl-6-oxa-3-aza-bicyclo[3.2.2]non-3-yl)-methanone

(3,4,5-Trimethoxy-phenyl)-((1R,5S)-5,7,7-trimethyl-6-oxa-3-aza-bicyclo[3.2.2]non-3-yl)-methanone

Conditions
ConditionsYield
With triethylamine In benzene for 6h; Heating;96%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

2-amino-1-(3,4,5-trimethoxyphenyl)ethanol acetic acid salt

2-amino-1-(3,4,5-trimethoxyphenyl)ethanol acetic acid salt

N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide
38165-13-8

N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane for 0.75h;96%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

2-[(R)-3-(3,4-Dichloro-phenyl)-pyrrolidin-3-yl]-ethanol
178961-26-7

2-[(R)-3-(3,4-Dichloro-phenyl)-pyrrolidin-3-yl]-ethanol

(R)-1-(3,4,5-trimethoxybenzoyl)-3-(3,4-dichlorophenyl)-3(2-hydroxyethyl)-pyrrolidine
177697-10-8

(R)-1-(3,4,5-trimethoxybenzoyl)-3-(3,4-dichlorophenyl)-3(2-hydroxyethyl)-pyrrolidine

Conditions
ConditionsYield
With sodium hydroxide; sodium hydrogencarbonate In water; acetone at 0℃;96%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

2-[(S)-3-(3,4-Dichloro-phenyl)-pyrrolidin-3-yl]-ethanol
177697-12-0

2-[(S)-3-(3,4-Dichloro-phenyl)-pyrrolidin-3-yl]-ethanol

(S)-1-(3,4,5-trimethoxybenzoyl)-3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidine
167262-66-0

(S)-1-(3,4,5-trimethoxybenzoyl)-3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidine

Conditions
ConditionsYield
With sodium hydroxide; sodium hydrogencarbonate In water; acetone at 0℃;96%
3-methylcyclohexan-1-amine
6850-35-7

3-methylcyclohexan-1-amine

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

3,4,5-Trimethoxy-N-(3-methyl-cyclohexyl)-benzamide

3,4,5-Trimethoxy-N-(3-methyl-cyclohexyl)-benzamide

Conditions
ConditionsYield
In benzene Ambient temperature;96%
cis-3,4-dihydroxytetrahydrothiophene
2657-70-7, 3976-75-8, 62729-29-7, 86827-92-1

cis-3,4-dihydroxytetrahydrothiophene

3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

C24H28O10S
245345-56-6

C24H28O10S

Conditions
ConditionsYield
With pyridine at 20℃; Acylation;96%
3,4,5-Trimethoxybenzoyl chloride
4521-61-3

3,4,5-Trimethoxybenzoyl chloride

3-iodo-6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene
264142-55-4

3-iodo-6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene

(6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophen-3-yl)(3,4,5-trimethoxyphenyl)methanone

(6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophen-3-yl)(3,4,5-trimethoxyphenyl)methanone

Conditions
ConditionsYield
With tert.-butyl lithium In tetrahydrofuran96%

4521-61-3Relevant articles and documents

Synthesis and biological evaluation of rigid polycyclic derivatives of the Diels-Alder adduct tricyclo[6.2.1.02,7]undeca-4,9-dien-3,6-dione

Ito, Felicia Megumi,Petroni, Jacqueline Marques,De Lima, Denis Pires,Beatriz, Adilson,Marques, Maria Rita,De Moraes, Manoel Odorico,Costa-Lotufo, Leticia Veras,Montenegro, Raquel Carvalho,Magalhaes, Hemerson Iury Ferreira,Do O Pessoa, Claudia

, p. 271 - 282 (2007)

Part of our research program concentrates on the discovery of new bioactive compounds prepared either by total synthesis or molecular transformation of compounds with bioactivity profiles. In this work we have focused our interest on chemical transformati

Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors

Yang, Jiabin,Su, Guoqiang,Ren, Yu,Chen, Yang

, p. 41 - 51 (2015)

Abstract The coagulation factor Xa (FXa) plays a central role in the blood coagulation cascade. Recent studies have shown that FXa is a particularly attractive target for the development of oral antithrombotic agents. In view of the excellent pharmaceutical properties of 1,2-phenylenediamine-based FXa inhibitors and the reported structureeactivity relationship (SAR) analysis of FXa inhibitors, we designed and synthesized a series of 3,4-diaminobenzoyl-based FXa inhibitors. Intensive SAR studies on this new series led to the discovery of 3,4-dimethoxyl substituted compound 7b. 7b is a highly potent, selective, direct FXa inhibitor with excellent in vivo antithrombotic activity.

Unusual C-H...π interactions in the structure of 3,4,5-trimethoxy-N-p-tolylbenzamide

Saeed, Aamer,Simpson, Jim

, p. 51 - 57 (2013)

3,4,5-trimethoxy-N-p-tolylbenzamide, C17H19NO 4, (1), is a benzanilide derivative derived from p-toluidine and 3,4,5-trimethoxybenzoyl chloride. The structure was identified from spectroscopic and elemental analysis data a

Micellar Catalysis for Sustainable Hydroformylation

Calamante, Massimo,Dei, Filippo,Maramai, Samuele,Migliorini, Francesca,Petricci, Elena

, p. 2794 - 2806 (2021/05/03)

It is here reported a fully sustainable and generally applicable protocol for the regioselective hydroformylation of terminal alkenes, using cheap commercially available catalysts and ligands, in mild reaction conditions (70 °C, 9 bar, 40 min). The process can take advantages from both micellar catalysis and microwave irradiation to obtain the linear aldehydes as the major or sole regioisomers in good to high yields. The substrate scope is largely explored as well as the application of hydroformylation in tandem with intramolecular hemiacetalization thus demonstrating the compatibility with a broad variety of functional groups. The reaction is efficient even in large scale and the catalyst and micellar water phase can be reused at least 5 times without any impact in reaction yields. The efficiency and sustainability of this protocol is strictly related to the in situ transformation of the aldehyde into the corresponding Bertagnini's salt that precipitates in the reaction mixture avoiding organic solvent mediated purification steps to obtain the final aldehydes as pure compounds.

Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker

AbdelHafez, El-Shimaa M. N.,Abdelhamid, Dalia,Aly, Omar M.,Maklad, Raed M.

, (2020/04/22)

Bis-hydrazides 13a-h were designed and synthesized as potential tubulin inhibitors selectively targeting the colchicine site between α- and β-tubulin subunits. The newly designed ring-B substituents were assisted at their ends by ‘anchor groups’ which are expected to exert binding interaction(s) with new additional amino acid residues in the colchicine site (beyond those amino acids previously reported to interact with reference inhibitors as CA-4 and colchicine). Conformational flexibility of bis-hydrazide linker assisted these ‘extra-binding’ properties through reliving ligands’ strains in the final ligand-receptor complexes. Compound 13f displayed the most promising computational and biological study results in the series: MM/GBSA binding energy of ?62.362 kcal/mol (extra-binding to Arg α:221, Thr β:353 & Lys β:254); 34% NCI-H522 cells’ death (at 10 μM), IC50 = 0.073 μM (MTT assay); significant cell cycle arrest at G2/M phase; 11.6% preG1 apoptosis induction and 83.1% in vitro tubulin inhibition (at concentration = IC50). Future researchers in bis-hydrazide tubulin inhibitors are advised to consider the 2-chloro-N-(4-substituted-phenyl)acetamide derivatives as compound 13f due to extra-binding properties of their ring B.

Probing the effects of the number and positions of –OCH3 and –CN substituents on color tuning of Ir(III) complex derivatives through a joint computational and experimental study

Qin, Xiao,Li, Ming,Xiang, Minghui,Luo, Yi,Jiao, Yan,Yuan, Rongao,Wang, Ning,Lu, Zhiyun,Pu, Xumei

, p. 470 - 481 (2019/06/03)

We performed a joint theoretical and experimental study on sixteen Ir(III) complexes bearing a similar molecular platform of bis(2-phenylbenzothiozolato-N,C2’) iridium(III) (acetylacetonate) by grafting – OCH3 group and/or – CN group on different positions of the C-related arene moiety of the C^N ligand (Cring). Our results reveal that the introduction of – CN renders an overall drop in the FMO energy levels while a reverse increase is observed for – OCH3. The ortho- and para-sites of the C-ring are more effective substitution positions to modulate the HOMO energy level due to the fact that the electronic density of HOMO mainly locates at them while the meta-site would induce a stronger impact on LUMO since the electronic density of LUMO mainly distributes over the position. Utilizing the synergistic effects of the substituents and the substituted positions, a wide color-tuning range from 479 nm to 637 nm was achieved, which covers nearly the whole window of visible spectrum. In particular, the tri-substituted Ir35mo4cn complex (λemmax=637 nm) may be a potential candidate for high efficiency red OLEDs materials due to its greatly enhanced absorption processes, relatively higher3MLCT (%), lower ΔES1–T1, enlarged separation between3MLCT/π–π* and3MC d–d states, and good hole and particle-transporting performances. Finally, six representative complexes were synthesized and their spectra were determined, which confirm the reliability of our computational strategy.

Pd(II)-Catalyzed asymmetric oxidative annulation of N-alkoxyheteroaryl amides and 1,3-dienes

Zhang, Tao,Shen, Hong-Cheng,Xu, Jia-Cheng,Fan, Tao,Han, Zhi-Yong,Gong, Liu-Zhu

, p. 2048 - 2051 (2019/03/29)

The first Pd(II)-catalyzed asymmetric oxidative annulation of N-alkoxyaryl amides and 1,3-dienes is reported, which features particular applicability for quick assembly of different types of chiral heterocycles with high yields and enantioselectivities. A novel chiral pyridine-oxazoline bearing a methoxyl group at the C-5 position and a gem-dimethyl group on the oxazoline moiety was found to be crucial for conversion.

Synthesis, biological evaluation and molecular docking studies of novel trimethoxy-ring derivatives as BRD4 inhibitors

Yang, Yan,Yao, Zhiyi

, p. 1319 - 1328 (2018/11/01)

Background: Bromodomain-containing protein 4 (BRD4) inhibitors synthesized with trimethoxy-ring refer to a new series of small molecular inhibitors. Currently, BRD4 offers the potential for research as a cancer therapeutic target. Based on previous studies, 17 trimethoxy-ring derivatives were designed as novel BRD4 inhibitors. Methods: All these new compounds were synthesized via the amide reaction. Their structures were identified by 1H NRM,13C NRM spectra and HRMS. In vitro antitumor activities of the new compounds were evaluated by MTT. Molecular docking studies were conducted to explain the binding interactions of these compounds with BRD4 protein. Results: A series of novel trimethoxy-ring derivatives were synthesized as BRD4 inhibitors and screened by testing their inhibition against HCT116, MCF-7, K562 and KMS-1 cell lines. Most of the newly synthesized compounds exhibited moderate-to-good inhibitory activity against HCT116, MCF-7, and K562 cell lines, whereas some showed inhibitory activity against the KMS-1 cell line. Conclusion: Compound 3g demonstrated the most potent anti-tumor activity against breast (MCF-7), leukemia (K562), multiple myeloma (KMS-1), and colon cancer (HCT116) cell lines.

Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents

Semenova, Marina N.,Demchuk, Dmitry V.,Tsyganov, Dmitry V.,Chernysheva, Natalia B.,Samet, Alexander V.,Silyanova, Eugenia A.,Kislyi, Victor P.,Maksimenko, Anna S.,Varakutin, Alexander E.,Konyushkin, Leonid D.,Raihstat, Mikhail M.,Kiselyov, Alex S.,Semenov, Victor V.

, p. 700 - 721 (2019/01/03)

A series of both novel and reported combretastatin analogues, including diarylpyrazoles, -isoxazoles, -1,2,3-triazoles, and -pyrroles, were synthesized via improved protocols to evaluate their antimitotic antitubulin activity using in vivo sea urchin embryo assay and a panel of human cancer cells. A systematic comparative structure-activity relationship studies of these compounds were conducted. Pyrazoles 1i and 1p, isoxazole 3a, and triazole 7b were found to be the most potent antimitotics across all tested compounds causing cleavage alteration of the sea urchin embryo at 1, 0.25, 1, and 0.5 nM, respectively. These agents exhibited comparable cytotoxicity against human cancer cells. Structure-activity relationship studies revealed that compounds substituted with 3,4,5-trimethoxyphenyl ring A and 4-methoxyphenyl ring B displayed the highest activity. 3-Hydroxy group in the ring B was essential for the antiproliferative activity in the diarylisoxazole series, whereas it was not required for potency of diarylpyrazoles. Isoxazoles 3 with 3,4,5-trimethoxy-substituted ring A and 3-hydroxy-4-methoxy-substituted ring B were more active than the respective pyrazoles 1. Of the azoles substituted with the same set of other aryl pharmacophores, diarylpyrazoles 1, 4,5-diarylisoxazoles 3, and 4,5-diaryl-1,2,3-triazoles 7 displayed similar strongest antimitotic antitubulin effect followed by 3,4-diarylisoxazoles 5, 1,5-diaryl-1,2,3-triazoles 8, and pyrroles 10 that showed the lowest activity. Introduction of the amino group into the heterocyclic core decreased the antimitotic antitubulin effect of pyrazoles, triazoles, and to a lesser degree of 4,5-diarylisoxazoles, whereas potency of the respective 3,4-diarylisoxazoles was increased.

Benzoylsalicylic acid derivatives as defense activators in tobacco and Arabidopsis

Kamatham, Samuel,Pallu, Reddanna,Pasupulati, Anil Kumar,Singh, Surya Satyanarayana,Gudipalli, Padmaja

, p. 160 - 169 (2017/08/29)

Systemic acquired resistance (SAR) is a long lasting inducible whole plant immunity often induced by either pathogens or chemical elicitors. Salicylic acid (SA) is a known SAR signal against a broad spectrum of pathogens in plants. In a recent study, we have reported that benzoylsalicylic acid (BzSA) is a SAR inducer in tobacco and Arabidopsis plants. Here, we have synthesized BzSA derivatives using SA and benzoyl chlorides of various moieties as substrates. The chemical structures of BzSA derivatives were elucidated using Infrared spectroscopy (IR), Nuclear magnetic spectroscopy (NMR) and High-resolution mass spectrometer (HRMS) analysis. The bioefficacy of BzSA derivatives in inducing defense response against tobacco mosaic virus (TMV) was investigated in tobacco and SA abolished transgenic NahG Arabidopsis plants. Interestingly, pre-treatment of local leaves of tobacco with BzSA derivatives enhanced the expression of SAR genes such as NPR1 [Non-expressor of pathogenesis-related (PR) genes 1], PR and other defense marker genes (HSR203, SIPK, WIPK) in systemic leaves. Pre-treatment of BzSA derivatives reduced the spread of TMV infection to uninfected areas by restricting lesion number and diameter both in local and systemic leaves of tobacco in a dose-dependent manner. Furthermore, pre-treatment of BzSA derivatives in local leaves of SA deficient Arabidopsis NahG plants induced SAR through AtPR1 and AtPR5 gene expression and reduced leaf necrosis and curling symptoms in systemic leaves as compared to BzSA. These results suggest that BzSA derivatives are potent SAR inducers against TMV in tobacco and Arabidopsis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4521-61-3